Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery: A Prospective, Single Center Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Robotic surgical systems have become a promising surgical assistance system, with unique advantages such as 3D high-definition visual system, highly flexible wrist-jointed instruments, and automatic fitering of hand tremors. Robotic surgical systems is applied in various fields including urology, general surgery, cardiothoracic surgery, head and neck surgery, and gynecology. Currently, the Da Vinci surgical robot system is the most widely used robot system globally. However, the Da Vinci robot system for single-port laparoscopic surgery has not yet been launched in China. Therefore, the investigators conduct a prespective, single-center study to evaluate the efficacy and safety of single-port surgical robot system in thoracic surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age between 18 and 75 years, regardless of gender.

• Patients who require endoscopic surgical treatment and have indications for lung segment/lobe resection; for pre-trial subjects, there is no restriction on the type of procedure, and inclusion is based on the investigator's judgment of having indications for thoracic surgery.

• Preoperative ASA classification of I-III.

• Voluntary participation in the clinical trial and willingness to provide informed.

⁃ consent, either by the subject or their guardian.

• Willingness to cooperate and complete trial follow-up and related examinations.

Locations
Other Locations
China
The First Affiliated Hospital of Guangzhou Medical University
RECRUITING
Guangzhou
Contact Information
Primary
Jianxing He, M.D.
hejx@vip.163.com
+86-20-83337792
Time Frame
Start Date: 2023-09-15
Estimated Completion Date: 2027-07-15
Participants
Target number of participants: 20
Treatments
Experimental: single-port robot group
Sponsors
Leads: The First Affiliated Hospital of Guangzhou Medical University

This content was sourced from clinicaltrials.gov